drugset / Trial / NCT03705442

Probiotics as Adjuvant Therapy in the Treatment of Metastatic Colorectal Cancer

NCT03705442

Phase 2 Unknown 76 enrolled Marin Golčić
RandomizedParallel-groupSingle-blindSupportive care

Summary

The research will be prospective, randomised, placebo controlled and double-blinded.The research will be carried on with regards to Helsinki Declaration and following the guidelines of Good Clinical Practice.

Timeline

Start
2018-02-09
Primary completion
2020-02-09
Completion
2020-02-09

Drugs

EvaluationDrugModalityDoseRoute
Background Loperamide Small molecule

Indications